A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease
Khasnavis, Tanya, Torres, Rosa J., Sommerfeld, Barbara, Puig, Juan Garcia, Chipkin, Richard, Jinnah, H.A.Language:
english
Journal:
Molecular Genetics and Metabolism
DOI:
10.1016/j.ymgme.2016.04.012
Date:
April, 2016
File:
PDF, 498 KB
english, 2016